Andrzej Dlugosz to oversee basic science research at Rogel Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Andrzej Dlugosz was named associate director for basic science research at the University of Michigan Rogel Cancer Center.

Dlugosz is the Poth Professor of Cutaneous Oncology and professor of dermatology and of cell and developmental biology at the University of Michigan. He co-leads the Rogel Cancer Center’s cancer biology program.

In his new role, Dlugosz will oversee the Rogel Cancer Center’s four basic science research programs, which focus on cancer biology, genetics, developmental therapeutics and immunology.

Dlugosz joined the faculty at the University of Michigan in 1997 and currently serves as associate chair for research in the Department of Dermatology.

His research focuses on how alterations in the Hedgehog signaling pathway contribute to cancer initiation, progression and maintenance in tumors arising in the skin and other organs. In more recent studies, he has also been investigating the molecular underpinnings of Merkel cell carcinoma.

Dlugosz replaces Stephen Weiss, who stepped down to build on his laboratory research efforts. Dlugosz’ appointment is effective Nov. 1.

Table of Contents

YOU MAY BE INTERESTED IN

Acting Director Dr. Krzysztof Ptak’s words reverberated throughout the meeting room—and the heads of several of us—during the National Cancer Institute’s Office of Cancer Centers update on the final day of the 2024 Association of American Cancer Institutes/Cancer Center Administrators Forum Annual Meeting in Chicago.
“Bridge to Bahia” exhibit.Source: Sylvester Comprehensive Cancer CenterKaren Estrada, a survivor of acute myeloid leukemia, used visual art to communicate with her two boys while undergoing a bone marrow transplant at Sylvester Comprehensive Cancer Center. Because Estrada’s treatment required isolation, and her young children could not yet read and write, she sought out other creative vessels to foster closeness between them.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login